Predicted protein targets (top 3)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | KCNJ1 | P48048 | 11/20 | 0.35 |
| ▸ | KCNH2 | Q12809 | 3/20 | 0.35 |
| ▸ | F11 | P03951 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Hydrochloric Acid SCHEMBL9930002 | 0.86 | IARS1 (0.32) | KCNH2 | |
| SCHEMBL9930091 | 0.85 | KCNH2 (0.33) | KCNJ1KCNH2 | |
| SCHEMBL9964926 | 0.85 | KCNH2 (0.37) | KCNH2 | |
| SCHEMBL9930160 | 0.84 | KCNJ1 (0.36) | KCNJ1KCNH2 | |
| SCHEMBL9930650 | 0.82 | KCNH2 (0.30) | KCNH2 | |
| SCHEMBL13429614 | 0.82 | KCNH2 (0.47) | KCNJ1KCNH2 | |
| SCHEMBL13429532 | 0.82 | KCNH2 (0.38) | KCNJ1KCNH2 | |
| SCHEMBL14069788 | 0.82 | KCNH2 (0.52) | KCNJ1KCNH2 | |
| SCHEMBL9930022 | 0.82 | KCNH2 (0.52) | KCNJ1KCNH2 | |
| SCHEMBL9968665 | 0.81 | KCNH2 (0.43) | KCNJ1KCNH2F11 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20120157434-A1 | Antimicrobial heterocyclic compounds for treatment of bacterial infections | CSO of MicuRx Pharmaceuticals, Inc. | 2012-06-21 | — | — | US | disclosed |
| US-20120157434-A1 | Antimicrobial heterocyclic compounds for treatment of bacterial infections | CSO of MicuRx Pharmaceuticals, Inc. | 2012-06-21 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20120157434-A1 | Antimicrobial heterocyclic compounds for treatment of bacterial infections | NISCH, NOD1, NQO1 | KCNJ1 1196/4885KCNH2 1295/4885F11 2852/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.